EC
Euclidean Capital Portfolio holdings
AUM
$392M
1-Year Est. Return
31.85%
This Fund
S&P 500
1 Year Est. Return
+31.85%
AUM
$392M
AUM Growth
+$22.9M
(+6.2%)
Holding
12
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard FTSE All-World ex-US ETF
VEU
$66.3B
| $244M | 62.09% |
3,243,484
+253,400
|
|
||
2
Vanguard Value ETF
VTV
$180B
| $102M | 26.01% |
520,000
|
|
||
3
iShares MSCI India ETF
INDA
$6.71B
| $17.3M | 4.41% |
369,600
|
|
||
4
Oric Pharmaceuticals
ORIC
$837M
| $12.5M | 3.2% |
989,410
|
|
||
5
Foghorn Therapeutics
FHTX
$221M
| $7.52M | 1.92% |
1,573,761
|
|
||
6
PMV Pharmaceuticals
PMVP
$63.5M
| $3.26M | 0.83% |
2,627,643
|
|
||
7
Alector
ALEC
$207M
| $2.81M | 0.72% |
1,307,858
|
|
||
8
Surrozen
SRZN
$285M
| $2.55M | 0.65% |
87,696
|
|
||
9
Tenaya Therapeutics
TNYA
$178M
| $703K | 0.18% |
1,015,705
|
|
||
|
10
Surrozen Inc Warrant
SRZNW
| $2.73K | ﹤0.01% |
170,833
|
|
||
|
RAPT
11
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-82,234
|
|
||
12
State Street SPDR S&P 500 ETF Trust
SPY
$779B
| – | – |
-4,104
|
|